Dermata Therapeutics, Inc. · NASDAQ:DRMA
Dermata Therapeutics, Inc. shareholders
As of Jun 30, 2026, 13 institutions reported holding Dermata Therapeutics, Inc., 3.0% of its shares. Largest: Geode Capital, Welch & Forbes LLC and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Dermata Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Geode Capital | 20,203 | 0.50% | −28,131 | Aug 12, 2026 |
| Welch & Forbes LLC | 20,000 | 0.50% | no change | Jul 30, 2026 |
| State Street | 18,747 | 0.47% | new | Aug 7, 2026 |
| UBS | 16,796 | 0.42% | −18,812 | Aug 13, 2026 |
| Susquehanna | 15,989 | 0.40% | new | Aug 14, 2026 |
| XTX Topco Ltd | 14,787 | 0.37% | new | Aug 14, 2026 |
| Advisory Alpha, LLC | 10,000 | 0.25% | new | Aug 11, 2026 |
| Tower Research Capital LLC (TRC) | 3,860 | 0.10% | +3,144 | Aug 11, 2026 |
| MCF Advisors LLC | 1,732 | 0.04% | no change | Aug 12, 2026 |
| Barclays | 270 | <0.01% | new | Aug 14, 2026 |